Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$2.38M Buy
7,619
+105
+1% +$30.8K 0.13% 85
2024
Q1
$2.14M Hold
7,514
0.12% 92
2023
Q4
$2.16M Hold
7,514
0.13% 91
2023
Q3
$2.02M Hold
7,514
0.13% 90
2023
Q2
$1.67M Sell
7,514
-148
-2% -$34.3K 0.1% 101
2023
Q1
$1.85M Buy
7,662
+170
+2% +$41.7K 0.12% 95
2022
Q4
$1.97M Hold
7,492
0.13% 90
2022
Q3
$1.69M Hold
7,492
0.13% 92
2022
Q2
$1.82M Sell
7,492
-150
-2% -$36.8K 0.13% 91
2022
Q1
$1.85M Sell
7,642
-70
-0.9% -$16.1K 0.12% 99
2021
Q4
$1.74M Sell
7,712
-300
-4% -$63.3K 0.11% 102
2021
Q3
$1.7M Buy
8,012
+10
+0.1% +$2.3K 0.12% 99
2021
Q2
$1.95M Hold
8,002
0.14% 94
2021
Q1
$1.99M Sell
8,002
-900
-10% -$215K 0.15% 92
2020
Q4
$2.05M Buy
8,902
+4,000
+82% +$922K 0.16% 89
2020
Q3
$1.25M Sell
4,902
-111
-2% -$27.5K 0.11% 103
2020
Q2
$1.18M Buy
5,013
+901
+22% +$206K 0.11% 96
2020
Q1
$834K Sell
4,112
-250
-6% -$54.6K 0.1% 91
2019
Q4
$1.05M Buy
4,362
+673
+18% +$148K 0.1% 94
2019
Q3
$714K Sell
3,689
-22
-0.6% -$4.22K 0.07% 104
2019
Q2
$684K Buy
3,711
+215
+6% +$38.5K 0.07% 108
2019
Q1
$664K Buy
+3,496
New +$668K 0.07% 116

Other funds holding AMGN

Charles D. Hyman's AMGN Position: Q2 2024 in Review

Charles D. Hyman increased its Amgen (AMGN) stake by 1.4% in Q2 2024, buying an estimated $30.8K and bringing the position to 7,619 shares worth $2.38M. The position accounts for 0.13% of the portfolio, ranked #85.

Charles D. Hyman first reported a position in AMGN in Q1 2019 and has held it in 22 quarters since. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • Charles D. Hyman held 7,619 shares of Amgen worth $2.38M as of Q2 2024.
  • Charles D. Hyman bought 105 Amgen shares in Q2 2024, an estimated $30.8K.
  • Amgen made up 0.13% of Charles D. Hyman's portfolio in Q2 2024, its #85 holding.
  • Charles D. Hyman first reported a position in Amgen in Q1 2019 and has held it in 22 quarters since.
  • 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Charles D. Hyman's 13F filing for Q2 2024, filed 25 Jul 2024.